Literature DB >> 27239463

Vascular Steal Syndrome, Optic Neuropathy, and Foreign Body Granuloma Reaction to Onyx-18 Embolization for Congenital Orbito-Facial Vascular Malformation.

Catherine Y Liu1, Marc A Yonkers1, Tiffany S Liu1, Don S Minckler1, Jeremiah P Tao1.   

Abstract

A 34-year-old patient presented with a right orbito-facial mass since childhood, consistent with a congenital arteriovenous (AV) malformation. Prior to presentation, she had multiple incomplete surgical resections and embolizations with N-butyl acetyl acrylate and Onyx-18. The patient reported gradual, progressive vision loss shortly after Onyx-18 embolization. Five months after embolization, she presented with decreased vision, disfigurement and mechanical ptosis relating to a large subcutaneous mass affecting the medial right upper eyelid and forehead. Significant exam findings included a visual acuity of 20/400 (20/60 prior to embolization), an afferent pupillary defect, and optic disc pallor. MRI and angiography revealed a persistent AV malformation with feeders from the ophthalmic artery and an absent choroidal flush to the right eye. Pathology from surgical resection showed a significant foreign body giant cell reaction to the embolization material adjacent to the vessels. We suggest that an incomplete embolization with Onyx-18 may have caused vascular steal syndrome from the ophthalmic artery.

Entities:  

Keywords:  Embolization; Ptosis; Vascular lesion

Year:  2016        PMID: 27239463      PMCID: PMC4881279          DOI: 10.1159/000443507

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  16 in total

1.  Sequential branch retinal artery occlusions following embolization of an intracranial meningioma.

Authors:  Tina Turner; Jonathan D Trobe; John P Deveikis
Journal:  Arch Ophthalmol       Date:  2002-06

2.  Endovascular management of direct carotid-cavernous sinus fistulas.

Authors:  X Lv; Y Li; X Yang; C Jiang; Z Wu
Journal:  Neuroradiol J       Date:  2012-03-01

3.  High-flow orbital arteriovenous malformation in a child: current management and options.

Authors:  Ryan Trombly; David I Sandberg; S Anthony Wolfe; John Ragheb
Journal:  J Craniofac Surg       Date:  2006-07       Impact factor: 1.046

4.  Preoperative onyx embolization of meningiomas fed by the ophthalmic artery: a case series.

Authors:  F Trivelatto; G S Nakiri; M Manisor; R Riva; M Al-Khawaldeh; I Kessler; C Mounayer
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-11       Impact factor: 3.825

5.  Combined endovascular and surgical approach for the treatment of palpebral arteriovenous malformations: experience of a single center.

Authors:  F Clarençon; R Blanc; C-J Lin; C Mounayer; O Galatoire; S Morax; J Moret; M Piotin
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

Review 6.  Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas.

Authors:  Alfons Krol; Carol J MacArthur
Journal:  Arch Facial Plast Surg       Date:  2005 Sep-Oct

7.  Arteriovenous malformations of the head and neck: natural history and management.

Authors:  M P Kohout; M Hansen; J J Pribaz; J B Mulliken
Journal:  Plast Reconstr Surg       Date:  1998-09       Impact factor: 4.730

Review 8.  Carotid-cavernous and orbital arteriovenous fistulas: ocular features, diagnostic and hemodynamic considerations in relation to visual impairment and morbidity.

Authors:  R de Keizer
Journal:  Orbit       Date:  2003-06

9.  Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation.

Authors:  Sabareesh Kumar Natarajan; Donald Born; Basavaraj Ghodke; Gavin W Britz; Laligam N Sekhar
Journal:  J Neurosurg       Date:  2009-07       Impact factor: 5.115

10.  Histomorphology of thrombus organization, neointima formation, and foreign body response in retrieved human aneurysms treated with hydrocoil devices.

Authors:  Monika Killer; Adam S Arthur; John D Barr; Bernd Richling; Gregory M Cruise
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2010-08       Impact factor: 3.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.